ArticleAddiction (Abingdon, England)2019

Extended-release injectable naltrexone (XR-NTX): a response to clinical issues raised by Brewer & Streel.

Brantley P Jarvis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.